Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q1 2016 · 10-Q
Revenue$2.42M$2.42M−10.7% vs Q1 2015 Net Income-$1.53M-$1.53MN/M vs Q1 2015 EPS Diluted-$0.03-$0.03N/M vs Q1 2015 Gross Profit$1,625,635+3.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flow-$112,258N/M Free Cash Flowderived-$112,258N/M Margins · derivedGross margin67.1%+9.0 pt vs Q1 2015
Operating margin-49.8%+49.2 pt vs Q1 2015
Net margin-63.3%+34.3 pt vs Q1 2015
ended Mar 31, 2016 · filed May 16, 2016 · 46 d after period end